Rocket Pharmaceuticals, Inc.股价在盘前交易中大幅上涨10.2%，此前美国食品药品监督管理局（FDA）正式批准了该公司针对一种致命性儿童疾病的新疗法。这一监管里程碑为患者带来了新的希望，同时也显著提升了市场对该公司未来发展的信心。
Rocket Pharmaceuticals, Inc.股价在盘前交易中大幅上涨10.2%，此前美国食品药品监督管理局（FDA）正式批准了该公司针对一种致命性儿童疾病的新疗法。这一监管里程碑为患者带来了新的希望，同时也显著提升了市场对该公司未来发展的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.